Studi Antiviral Andrographis Paniculata, For Herpes Simplex Virustipe 1 (HSV-1) Treatment: In Slico Study
DOI:
https://doi.org/10.22270/ajprd.v9i6.1036Keywords:
HSV-1, Andrographis paniculate, N, in silico studiesAbstract
Herpes simplex virus type 1 (HSV-1) is a lifelong infectious disease. Research and drug development for this disease continues to be developed. Andrographis paniculata or commonly known as Sambiloto is a plant that is commonly used empirically as an HSV-1 drug. Further research is needed to determine the effectiveness of these plants as candidates for HSV-1 treatment. This study will determine several bioactive compounds contained in Sambiloto against the HSV-1 receptor in an insilico study which can be the basis for the discovery of new drugs in the treatment of HSV-1 infection.
Downloads
References
2. Pongmuangmul S, Phumiamorn S, Sanguansermsri P, Wongkattiya N, Fraser IH, Sanguansermsri D. Anti-herpes simplex virus activities of monogalactosyl diglyceride and digalactosyl diglyceride from Clinacanthus nutans, a traditional Thai herbal medicine. Asian Pac J Trop Biomed. 2016;6(3):192-197. doi:10.1016/j.apjtb.2015.12.014
3. Tajidin NE, Shaari K, Maulidiani M, Salleh NS, Ketaren BR, Mohamad M. Metabolite profiling of Andrographis paniculata (Burm. f.) Nees. young and mature leaves at different harvest ages using 1H NMR-based metabolomics approach. Sci Rep. 2019;9(1):1-10. doi:10.1038/s41598-019-52905-z
4. Chao WW, Lin BF. Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med. 2010;5:1-15. doi:10.1186/1749-8546-5-17
5. https://www.rcsb.org/.
6. https://pubchem.ncbi.nlm.nih.gov/.
7. Weni M, Safithri M, Seno DSH. Molecular Docking of Active Compounds Piper crocatum on the A-Glucosidase Enzyme as Antidiabetic. Indones J Pharm Sci Technol. 2020;7(2):64. doi:10.24198/ijpst.v7i2.21120
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).